1
|
Marchington DR, Scott-Brown M, Barlow DH, Poulton J. Mosaicism for mitochondrial DNA polymorphic variants in placenta has implications for the feasibility of prenatal diagnosis in mtDNA diseases. Eur J Hum Genet 2006; 14:816-23. [PMID: 16670690 DOI: 10.1038/sj.ejhg.5201618] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Women who have had a child with mitochondrial DNA (mtDNA) disease need to know the risk of recurrence, but this risk is difficult to estimate because mutant and wild-type (normal) mtDNA coexist in the same person (heteroplasmy). The possibility that a single sample may not reflect the whole organism both impedes prenatal diagnosis of most mtDNA diseases, and suggests radical alternative strategies such as nuclear transfer. We used naturally occurring mtDNA variants to investigate mtDNA segregation in placenta. Using large samples of control placenta, we demonstrated that the level of polymorphic heteroplasmic mtDNA variants is very similar in mother, cord blood and placenta. However, where placental samples were very small (< 10 mg) there was clear evidence of variation in the distribution of mtDNA polymorphic variants. We present the first evidence for variation in mutant load, that is, mosaicism for mtDNA polymorphic variants in placenta. This suggests that mtDNA mutants may segregate in placenta and that a single chorionic villous sample (CVS) may be unrepresentative of the whole placenta. Duplicates may be necessary where CVS are small. However, the close correlation of mutant load in maternal, fetal blood and placental mtDNA suggests that the average load in placenta does reflect the load of mutant mtDNA in the baby. Provided that segregation of neutral and pathogenic mtDNA mutants is similar in utero, our results are generally encouraging for developing prenatal diagnosis for mtDNA diseases. Identifying mtDNA segregation in human placenta suggests studies of relevance to placental evolution and to developmental biology.
Collapse
Affiliation(s)
- David R Marchington
- Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford OX3 9DU, UK
| | | | | | | |
Collapse
|
2
|
Jacobs LJAM, de Wert G, Geraedts JPM, de Coo IFM, Smeets HJM. The transmission of OXPHOS disease and methods to prevent this. Hum Reprod Update 2005; 12:119-36. [PMID: 16199488 DOI: 10.1093/humupd/dmi042] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Diseases owing to defects of oxidative phosphorylation (OXPHOS) affect approximately 1 in 8,000 individuals. Clinical manifestations can be extremely variable and range from single-affected tissues to multisystemic syndromes. In general, tissues with a high energy demand, like brain, heart and muscle, are affected. The OXPHOS system is under dual genetic control, and mutations in both nuclear and mitochondrial genes can cause OXPHOS diseases. The expression and segregation of mitochondrial DNA (mtDNA) mutations is different from nuclear gene defects. The mtDNA mutations can be either homoplasmic or heteroplasmic and in the latter case disease becomes manifest when the mutation exceeds a tissue-specific threshold. This mutation load can vary between tissues and often an exact correlation between mutation load and phenotypic expression is lacking. The transmission of mtDNA mutations is exclusively maternal, but the mutation load between embryos can vary tremendously because of a segregational bottleneck. Diseases by nuclear gene mutations show a normal Mendelian inheritance pattern and often have a more constant clinical manifestation. Given the prevalence and severity of OXPHOS disorders and the lack of adequate therapy, existing and new methods for the prevention of transmission of OXPHOS disorders, like prenatal diagnosis (PND), preimplantation genetic diagnosis (PGD), cytoplasmic transfer (CT) and nuclear transfer (NT), are technically and ethically evaluated.
Collapse
Affiliation(s)
- L J A M Jacobs
- Department of Genetics and Cell Biology, University of Maastricht, 6200 MD Maastricht, The Netherlands
| | | | | | | | | |
Collapse
|
3
|
Tejerizo-García A, Hernández-Hernández L, Henríquez A, González-Rodríguez S, Ruiz M, Alcántara R, Martínez del Val M, Lanchares J, Tejerizo-López L. Enfermedades mitocondriales y gestación. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA 2005. [DOI: 10.1016/s0210-573x(05)73478-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Racine AC, Blanchot G, Le Vaillant C, Boog G. Grossesse chez une patiente atteinte de cytopathie mitochondriale. ACTA ACUST UNITED AC 2004; 33:131-9. [PMID: 15052179 DOI: 10.1016/s0368-2315(04)96412-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We report a case of a pregnant woman with a mitochondrial disorder affecting the energy-generating pathway of oxidative phosphorylation which was suggested when the patient presented the progressive clinical phenotype of a proximal tubular renal insufficiency, a muscular weakness of extremities, a bilateral optic neuropathy and a brain magnetic resonance imaging suggesting diffuse leucoencephalopathy. Her diagnosis was made on the basis of abnormal mitochondria on a muscle biopsy and of spectrophotometric deficiencies of the complexes I, II+III and IV of the respiratory chain. No specific molecular mutation could be detected. Her pregnancy was complicated by a severe preeclampsia, an insulin requiring gestational diabetes and a worrying renal failure which precipitated the premature delivery by cesarean section at 30 weeks gestation. The clinical course of the female neonate weighing 1030 grams was uneventful. At two Years of age she showed no sign of mitochondrial disease. But the postpartum course of the mother was complicated by seizures and a terminal renal failure leading presently to dialysis, but requiring a kidney transplantation in the near future.
Collapse
Affiliation(s)
- A-C Racine
- Service d'Obstétrique et de Médecine Foetale, Hôpital Mère et Enfant, CHU, Quai Moncousu, 44093 Nantes Cedex 1
| | | | | | | |
Collapse
|
5
|
Niers L, van den Heuvel L, Trijbels F, Sengers R, Smeitink J. Prerequisites and strategies for prenatal diagnosis of respiratory chain deficiency in chorionic villi. J Inherit Metab Dis 2003; 26:647-58. [PMID: 14707513 DOI: 10.1023/b:boli.0000005605.57420.b4] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Prenatal diagnosis for respiratory chain deficiencies is a complex procedure that requires a thorough diagnostic work-up of the index patient. This includes confirmation of the clinical and metabolic evaluations through histological and enzymatic examinations of tissue biopsies. Prenatal diagnosis currently relies on biochemical assays of respiratory chain complexes in chorionic villi or amniocytes and is possible by mutation analysis of nuclear genes in a limited but increasing proportion of cases. Based on a recent survey of prenatal diagnosis in families with complex I and complex IV deficiencies, performed at Nijmegen Centre for Mitochondrial Disorders (NCMD), prerequisites and strategies for performing prenatal diagnosis have been developed to increase reliability. Biochemical investigations in chorionic villi can be done reliably if the respiratory chain enzyme deficiency is expressed in both skeletal muscle and skin fibroblasts to rule out tissue specificity. No mitochondrial DNA defects must be suspected or established. The NCMD does not offer prenatal diagnosis until all the prerequisites have been confirmed. We expect prenatal diagnosis at the molecular level to become more feasible in time as the mutational spectrum broadens with advances in medical research.
Collapse
Affiliation(s)
- L Niers
- Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, The Netherlands
| | | | | | | | | |
Collapse
|
6
|
Abstract
Mitochondrial disorders are caused by deficient respiratory chain function, resulting in a complex series of pathophysiological events. Genetic counselling is complicated because the respiratory chain subunits are encoded by both nuclear and mitochondrial DNA genes. Only a minority of the nuclear genes involved in mitochondrial function have been identified, and even fewer are associated with human mitochondrial disease. Mutations in mitochondrial DNA are particularly challenging because of the complexities of mitochondrial genetics: the mitochondrial DNA is strictly maternally inherited; there are 10(3)-10(4) copies of mitochondrial DNA in somatic cells; affected individuals often have a mixture of normal and mutated mitochondrial DNA (mitochondrial DNA heteroplasmy), the level of mutated mitochondrial DNA (the mitochondrial DNA mutation load) may vary widely between different maternally related individuals, between tissues and with time; a particular minimal threshold of mutated mitochondrial DNA is required to impair respiratory chain function; and there is not always a good correlation between mutant load and phenotype.
Collapse
Affiliation(s)
- Caroline Graff
- Karolinska Institute, Department of Medical Nutrition and Biosciences, Novum, Huddinge University Hospital, Stockholm, Sweden
| | | | | |
Collapse
|
7
|
Borchert A, Wolf NI, Wilichowski E. Current concepts of mitochondrial disorders in childhood. Semin Pediatr Neurol 2002; 9:151-9. [PMID: 12138999 DOI: 10.1053/spen.2002.33800] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Respiratory chain deficiencies have long been regarded as rare neuromuscular diseases mostly originating from mutations in the mitochondrial genome. Research in the last years has created quite a different picture. The clinical spectrum has expanded to multiorgan disease manifestation, with an estimated minimum incidence in children of 1:11,000. Mutations in the nuclear genome have been discovered in recent years, thereby adding mendelian genetics to the broadened spectrum of mitochondrial disease. This review summarizes recent advances in mitochondrial disorders with a special focus on childhood presentation and therapeutic approaches that may prove useful in the future.
Collapse
Affiliation(s)
- Astrid Borchert
- Department of Neuropediatrics, University Children's Hopsital, Heidelberg, Germany
| | | | | |
Collapse
|
9
|
Bénit P, Chretien D, Kadhom N, de Lonlay-Debeney P, Cormier-Daire V, Cabral A, Peudenier S, Rustin P, Munnich A, Rötig A. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 2001; 68:1344-52. [PMID: 11349233 PMCID: PMC1226121 DOI: 10.1086/320603] [Citation(s) in RCA: 185] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2001] [Accepted: 03/19/2001] [Indexed: 11/03/2022] Open
Abstract
Reduced nicotinamide adenine dinucleotide (NADH):ubiquinone oxidoreductase (complex I) is the largest complex of the mitochondrial respiratory chain and complex I deficiency accounts for approximately 30% cases of respiratory-chain deficiency in humans. Only seven mitochondrial DNA genes, but >35 nuclear genes encode complex I subunits. In an attempt to elucidate the molecular bases of complex I deficiency, we studied the six most-conserved complex I nuclear genes (NDUFV1, NDUFS8, NDUFS7, NDUFS1, NDUFA8, and NDUFB6) in a series of 36 patients with isolated complex I deficiency by denaturing high-performance liquid chromatography and by direct sequencing of the corresponding cDNA from cultured skin fibroblasts. In 3/36 patients, we identified, for the first time, five point mutations (del222, D252G, M707V, R241W, and R557X) and one large-scale deletion in the NDUFS1 gene. In addition, we found six novel NDUFV1 mutations (Y204C, C206G, E214K, IVS 8+41, A432P, and del nt 989-990) in three other patients. The six unrelated patients presented with hypotonia, ataxia, psychomotor retardation, or Leigh syndrome. These results suggest that screening for complex I nuclear gene mutations is of particular interest in patients with complex I deficiency, even when normal respiratory-chain-enzyme activities in cultured fibroblasts are observed.
Collapse
MESH Headings
- Abnormalities, Multiple/enzymology
- Abnormalities, Multiple/genetics
- Abnormalities, Multiple/pathology
- Amino Acid Sequence
- Base Sequence
- Catalytic Domain
- Cell Nucleus/genetics
- Child, Preschool
- Chromatography, High Pressure Liquid
- DNA Mutational Analysis
- Electron Transport/genetics
- Electron Transport Complex I
- Exons/genetics
- Female
- Fibroblasts
- Genetic Counseling
- Haplotypes/genetics
- Humans
- Infant
- Infant, Newborn
- Leigh Disease/enzymology
- Leigh Disease/genetics
- Leigh Disease/pathology
- Mitochondria, Muscle/enzymology
- Mitochondria, Muscle/metabolism
- Mitochondria, Muscle/pathology
- Molecular Sequence Data
- NADH Dehydrogenase
- NADH, NADPH Oxidoreductases/chemistry
- NADH, NADPH Oxidoreductases/deficiency
- NADH, NADPH Oxidoreductases/genetics
- Nucleic Acid Denaturation
- Point Mutation/genetics
- Proteins/chemistry
- Proteins/genetics
- Sequence Alignment
- Sequence Deletion/genetics
Collapse
Affiliation(s)
- Paule Bénit
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Dominique Chretien
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Nohman Kadhom
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Pascale de Lonlay-Debeney
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Valérie Cormier-Daire
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Aguinaldo Cabral
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Sylviane Peudenier
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Pierre Rustin
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Arnold Munnich
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| | - Agnès Rötig
- INSERM U393, Service de Génétique, Hôpital Necker-Enfants Malades, Paris; Hospital de Santa Maria, Lisbon; and Hôpital Sud, Rennes, France
| |
Collapse
|